These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30846172)

  • 21. The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Stepan KO; Mazul AL; Skillington SA; Paniello RC; Rich JT; Zevallos JP; Jackson RS; Pipkorn P; Massa S; Puram SV
    Head Neck; 2021 Jun; 43(6):1797-1811. PubMed ID: 33620125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.
    Li YJ; Luo Y; Xie XQ; Li P; Wang F
    Radiother Oncol; 2018 Nov; 129(2):396-402. PubMed ID: 30082142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
    Zeng Q; Wang J; Lv X; Li J; Yin LJ; Xiang YQ; Guo X
    BMC Cancer; 2016 Aug; 16(1):693. PubMed ID: 27577729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.
    Siti-Azrin AH; Norsa'adah B; Naing NN
    BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and outcome for nasopharyngeal carcinoma.
    Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
    Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
    Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients.
    Chen JY; Wu X; Hong CQ; Chen J; Wei XL; Zhou L; Zhang HX; Huang YT; Peng L
    Clin Transl Oncol; 2017 Jan; 19(1):84-90. PubMed ID: 27119734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study.
    Zhang P; Zhang L; Liu H; Zhao L; Li Y; Shen JX; Liu Q; Liu MZ; Xi M
    Cancer Res Treat; 2017 Jul; 49(3):695-705. PubMed ID: 27737535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score-Adjusted, Population-Based Study.
    Lin C; Wu J; Ding S; Goh C; Andriani L; Shen K; Zhu L
    Cancer Res Treat; 2020 Apr; 52(2):552-562. PubMed ID: 31801318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
    Hong RL; Hsiao CF; Ting LL; Ko JY; Wang CW; Chang JTC; Lou PJ; Wang HM; Tsai MH; Lai SC; Liu TW
    Ann Oncol; 2018 Sep; 29(9):1972-1979. PubMed ID: 30016391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
    Cao X; Han Y; He L; Xiang J; Wen Z
    Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis.
    Huang Y; Chen W; Haque W; Verma V; Xing Y; Teh BS; Brian Butler E
    Cancer Med; 2018 Apr; 7(4):1093-1101. PubMed ID: 29493889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.
    Xie R; Xia B; Zhang X; Hu W; Zhao R; Xie C; Wang J; Zhang N; Wu S
    Oncotarget; 2016 Dec; 7(49):81918-81925. PubMed ID: 27636993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
    Zhong JT; Wang HJ; Yu J; Zhang JH; Wang SF; Yang X; Su W
    Cancer Biomark; 2017; 19(2):213-220. PubMed ID: 28269757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Kong L; Zhang Y; Hu C; Guo Y; Lu JJ
    Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004-2008.
    Chee Ee Phua V; Loo WH; Yusof MM; Wan Ishak WZ; Tho LM; Ung NM
    Asian Pac J Cancer Prev; 2013; 14(8):4567-70. PubMed ID: 24083703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between time from diagnosis to treatment and survival of patients with nasopharyngeal carcinoma: A population-based cohort study.
    Wei X; Yu S; Wang J; Xiang Z; Liu L; Min Y
    Curr Probl Cancer; 2024 Feb; 48():101060. PubMed ID: 38211418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of second primary malignancies after nasopharyngeal carcinoma: a population-based cohort study in Taiwan.
    Lin C; Lin SW; Weng SF; Lin YS
    Head Neck; 2014 Feb; 36(2):209-14. PubMed ID: 23729214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study.
    Zhang L; Dong D; Li H; Tian J; Ouyang F; Mo X; Zhang B; Luo X; Lian Z; Pei S; Dong Y; Huang W; Liang C; Liu J; Zhang S
    EBioMedicine; 2019 Feb; 40():327-335. PubMed ID: 30642750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.